subject area of
- A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck Conference Paper
- AML refractory to primary induction with Ida-FLAG has a poor clinical outcome Academic Article
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease Academic Article
- Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis Academic Article
- Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs Academic Article
- Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease Academic Article
- ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment Academic Article
- Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease Academic Article
- Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia Academic Article
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial Academic Article
- N2 is not N2 is not N2 Academic Article
- Oral budesonide for induction of remission in ulcerative colitis Academic Article
- Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis Academic Article
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis Academic Article
- Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis Academic Article
- Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia Academic Article
- Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis Academic Article
- Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived Academic Article
- Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia Academic Article
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis Academic Article
- The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Academic Article
- The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies Academic Article
- Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial Academic Article
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Academic Article